Description
PRINCIPIO ACTIVO: INSULINA HUMANA NPH
Vía de administración: Intravenosa (IV) o subcutánea (SC)
40 ML Envase
LAURIL ETER SULFATO DE SODIO 0
CRA HINDS LIQ RSA RCA 90ML TASIGNA PRINCIPIO ACTIVO: INSULINA HUMANA NPH
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
